BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29277640)

  • 1. Using Image Attributes to Assure Accurate Particle Size and Count Using Nanoparticle Tracking Analysis.
    Defante AP; Vreeland WN; Benkstein KD; Ripple DC
    J Pharm Sci; 2018 May; 107(5):1383-1391. PubMed ID: 29277640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA).
    Chan MY; Dowling QM; Sivananthan SJ; Kramer RM
    Methods Mol Biol; 2017; 1494():239-252. PubMed ID: 27718198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.
    Gruia F; Parupudi A; Polozova A
    PDA J Pharm Sci Technol; 2015; 69(3):427-39. PubMed ID: 26048748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways.
    McComiskey KPM; Tajber L
    Eur J Pharm Biopharm; 2018 Sep; 130():314-326. PubMed ID: 30012404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.
    Filipe V; Hawe A; Jiskoot W
    Pharm Res; 2010 May; 27(5):796-810. PubMed ID: 20204471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Factors Affecting Nanoparticle Tracking Analysis Results With Synthetic and Protein Nanoparticles.
    Krueger AB; Carnell P; Carpenter JF
    J Pharm Sci; 2016 Apr; 105(4):1434-43. PubMed ID: 27019960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle Tracking Analysis for Multiparameter Characterization and Counting of Nanoparticle Suspensions.
    Griffiths D; Carnell-Morris P; Wright M
    Methods Mol Biol; 2020; 2118():289-303. PubMed ID: 32152988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle tracking analysis of particle size and concentration detection in suspensions of polymer and protein samples: Influence of experimental and data evaluation parameters.
    Gross J; Sayle S; Karow AR; Bakowsky U; Garidel P
    Eur J Pharm Biopharm; 2016 Jul; 104():30-41. PubMed ID: 27108267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity.
    Caputo F; Clogston J; Calzolai L; Rösslein M; Prina-Mello A
    J Control Release; 2019 Apr; 299():31-43. PubMed ID: 30797868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles.
    Tian X; Nejadnik MR; Baunsgaard D; Henriksen A; Rischel C; Jiskoot W
    J Pharm Sci; 2016 Nov; 105(11):3366-3375. PubMed ID: 27663383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Tracking Analysis for Determination of Hydrodynamic Diameter, Concentration, and Zeta-Potential of Polyplex Nanoparticles.
    Wilson DR; Green JJ
    Methods Mol Biol; 2017; 1570():31-46. PubMed ID: 28238128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of two-dimensional Brownian motion dynamics in applying nanoparticle tracking analysis.
    Van der Meeren P; Kasinos M; Saveyn H
    Methods Mol Biol; 2012; 906():525-34. PubMed ID: 22791461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.
    Zhou C; Krueger AB; Barnard JG; Qi W; Carpenter JF
    J Pharm Sci; 2015 Aug; 104(8):2441-50. PubMed ID: 26017684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Evaluation of Microfluidic Resistive Pulse Sensing for Quantification and Sizing of Nanometer- and Micrometer-Sized Particles in Biopharmaceutical Products.
    Grabarek AD; Weinbuch D; Jiskoot W; Hawe A
    J Pharm Sci; 2019 Jan; 108(1):563-573. PubMed ID: 30176253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle tracking analysis and statistical mixture distribution analysis to quantify nanoparticle-vesicle binding.
    Foreman-Ortiz IU; Ma TF; Hoover BM; Wu M; Murphy CJ; Murphy RM; Pedersen JA
    J Colloid Interface Sci; 2022 Jun; 615():50-58. PubMed ID: 35123359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Dispersion of Nanoparticles: A Comprehensive Evaluation of Size Distribution with 9 Size Measurement Methods.
    Varenne F; Makky A; Gaucher-Delmas M; Violleau F; Vauthier C
    Pharm Res; 2016 May; 33(5):1220-34. PubMed ID: 26864858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference from Proteins and Surfactants on Particle Size Distributions Measured by Nanoparticle Tracking Analysis (NTA).
    Bai K; Barnett GV; Kar SR; Das TK
    Pharm Res; 2017 Apr; 34(4):800-808. PubMed ID: 28155075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and Sizing of Submicron Particles in Biologics With Interferometric Scattering Microscopy.
    Wong NA; Uchida NV; Dissanayake TU; Patel M; Iqbal M; Woehl TJ
    J Pharm Sci; 2020 Jan; 109(1):881-890. PubMed ID: 31160046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nanosize Particle Analysis by Dynamic Light Scattering (DLS)].
    Ashizawa K
    Yakugaku Zasshi; 2019; 139(2):237-248. PubMed ID: 30713234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable Threshold Method for Determining the Boundaries of Imaged Subvisible Particles.
    Cavicchi RE; Collett C; Telikepalli S; Hu Z; Carrier M; Ripple DC
    J Pharm Sci; 2017 Jun; 106(6):1499-1507. PubMed ID: 28209364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.